The US Drug Enforcement Administration (DEA) is focusing on the wrong metrics by restricting the use of opioid pain medications and prosecuting doctors over the potential risk of drug diversion, says L. Joseph Parker. He argues that this approach has contributed to patient deaths and forced many to seek pain relief from unofficial sources, including counterfeit pills containing fentanyl. Parker calls for medical personnel, rather than law enforcement, to determine medication quotas.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
